Position in ZTS
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$1,833,364
-$766,310 QoQ
Shares Held
25,513
+16.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#494
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 4%
Shared 0%
None 96%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Robeco Institutional Asset Management B.V. holds $403,524,623 across 13 Drug Manufacturers - Specialty & Generic names. ZTS ranks #9 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
18,021,100 | $261,125,739 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
123,056 | $66,675,432 | |
| 3 | VTRS |
Viatris Inc
|
2,080,468 | $33,037,831 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
107,976 | $18,198,275 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
128,116 | $5,256,599 | |
| 6 | ALKS |
Alkermes plc.
|
92,592 | $4,851,357 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
174,003 | $4,282,213 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
164,014 | $4,161,035 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,833,364 | 25,513 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $2,599,674 | 21,992 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $2,273,441 | 18,069 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $5,607,567 | 38,324 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $85,062,615 | 545,448 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $62,734,284 | 381,016 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $92,621,142 | 568,472 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $129,636,779 | 663,511 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $114,186,164 | 658,665 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $112,717,549 | 666,140 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $129,664,195 | 656,960 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $115,918,698 | 666,276 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $113,706,302 | 660,277 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $128,990,001 | 774,994 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $113,098,497 | 771,740 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $135,264,354 | 912,161 | Shares | Defined | 2022-12-01 | |
| 2022-06-30 | $177,137,286 | 1,030,527 | Shares | Defined | 2022-12-01 | |
| 2022-03-31 | $220,976,937 | 1,171,732 | Shares | Defined | 2022-12-01 | |
| 2021-12-31 | $350,206,720 | 1,435,097 | Shares | Defined | 2022-12-01 | |
| 2021-09-30 | $237,248,592 | 1,222,049 | Shares | Defined | 2022-12-01 | |
| 2021-06-30 | $211,373,425 | 1,134,221 | Shares | Defined | 2022-12-01 | |
| 2021-03-31 | $183,621,522 | 1,165,999 | Shares | Defined | 2022-12-01 | |
| 2020-12-31 | $176,316,418 | 1,065,356 | Shares | Defined | 2022-12-01 | |
| 2020-09-30 | $120,094,836 | 726,219 | Shares | Defined | 2021-01-19 | |
| 2020-06-30 | $98,058,697 | 715,548 | Shares | Defined | 2021-01-19 | |
| 2020-03-31 | $79,848,310 | 678,463 | Shares | Defined | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||